WE ACCEPT MOST MAJOR INSURANCES!
At The Regenerative Center, our providers have over a decade of expertise in regenerative medicine to provide innovative stem cell therapy options for the treatment of Parkinson’s Disease (PD). The Regenerative Center’s Medical Director, Dr. Sean McDonald, was the lead physician in administering an FDA approved clinical trial using stem cell therapy for Bradykinesia due to Parkinson’s Disease. Our leading-edge protocols utilize the remarkable capabilities of Stem Cells (MSCs) to potentially slow down the progression of PD and improve the quality of life for those affected by this neurodegenerative disorder.
The Regenerative Center specializes in Advanced Regenerative Medicine Treatments for chronic conditions impacting patients’ overall health and wellness. We are conveniently located in Paducah, Kentucky, however, patients travel from across the United States and abroad for our innovative, non-surgical treatments utilizing regenerative medicine. A Video-Chat, Phone Call, or In-Person Case Review is available for your convenience with Regenerative Medicine Specialist, Dr. Sean McDonald.
Our Patient Care Coordinator will contact you to confirm your time.
At The Regenerative Center, we are dedicated to providing personalized, innovative care that goes beyond the limitations of conventional therapies. Our experienced team is committed to delivering treatments tailored to the individual needs of our patients, with a focus on safety, efficacy, and the pursuit of better health outcomes.
We believe in empowering our patients with cutting-edge therapies that have the potential to restore function and enhance life. Our application of MSCs for Parkinson’s Disease is at the forefront of regenerative medicine, offering new hope and possibilities for those seeking alternatives to traditional PD treatments.
If you or a loved one are facing the challenges of Parkinson’s Disease, we invite you to discover the regenerative options available at The Regenerative Center. Together, we can explore how stem cell therapy may open new doors to managing and potentially improving the conditions associated with PD. Contact us to learn more about our specialized care and how we can support your journey toward regaining control over your health.
Parkinson’s Disease is a progressive nervous system disorder that predominantly affects motor function, leading to symptoms such as tremors, stiffness, and difficulty with balance and coordination. The disease is characterized by the degeneration of dopamine-producing neurons in the brain. Traditional treatments for PD, including medications like Levodopa or dopamine agonists, aim to replenish dopamine or mimic its action. However, these treatments often lose effectiveness over time and do not halt the underlying neurodegeneration.
Our approach at The Regenerative Center involves the use of Mesenchymal Stem Cells, which have shown promise in not only providing symptomatic relief but also in offering neuroprotective effects that may slow the degeneration of dopaminergic neurons. MSCs have the potential to modulate the immune system, reduce inflammation, and secrete factors that promote neuron survival and regeneration.
The therapeutic potential of MSCs in PD is multifaceted. They can differentiate into various cell types and release trophic factors that support the growth and repair of neuronal cells. Our ongoing research and treatment protocols aim to leverage these properties to introduce new solutions for managing Parkinson’s Disease.
Large-scale, long-term studies are still needed to confirm efficacy and safety for various conditions.
Individual responses to stem cell therapy can vary significantly, and success rates are not yet fully established.
As with any medical intervention, there are potential risks, such as infections or adverse reactions, which should be carefully evaluated.
Availability varies globally, and coverage by insurance is often limited.